Low dose naltrexone for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 tweeters
wikipedia: 1 Wikipedia page

video: 1 video uploader

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 162 Mendeley

Summary Twitter Wikipedia Video Dimensions citations

So far, Altmetric has seen 15 tweets from 15 users, with an upper bound of 39,641 followers.

@leanhealth @cote_langues Interessant! Ich hab noch folgendes zu #Naltrexon gelesen: https://t.co/z4okA2SLsf

Reply Retweet Favourite

^https://t.co/OgdmmYV0EE ^^https://t.co/tN13385I3O

Reply Retweet Favourite

@disableddawn @DiamonDie @JoannaNoBanana Was scrolling and saw your tweet. I've had Crohn's for several decades- LDN really does work. I think you may be missing out on a very helpful (no side effect) therapeutic https://t.co/FV7wJnSqUI

Reply Retweet Favourite

@Rei_do_Norte21M Uma terceira coisa a tentar é isso LND - naltrexona em baixas doses - https://t.co/UnLtCFIc3B

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 11 additional tweets.